Erianin mitigates diabetic cardiomyopathy via adenosine monophosphate-activated protein kinase-nuclear factor erythroid 2-related factor 2-heme oxygenase-1 pathway activation

Figure 4 Echocardiographic parameters in type 2 diabetic mice. A: Left ventricular ejection fraction (LVEF) (%); B: Left ventricular fractional shortening (LVFS) (%); C: Left ventricular internal dimension at diastole (LVIDd) (mm); D: Left ventricular internal dimension at systole (LVIDs) (mm). Bar charts represent the mean ± SEM, n = 8. ^cP < 0.001 vs control group; ^dP < 0.05 vs model group; ^eP < 0.01 vs model group; ^fP < 0.001 vs model group.